These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18268934)

  • 1. Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
    Kamin W; Schwabe A; Krämer I
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):599-607. PubMed ID: 18268934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
    Krämer I; Schwabe A; Lichtinghagen R; Kamin W
    Pharmazie; 2007 Oct; 62(10):760-6. PubMed ID: 18236781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
    Donohue JF; Kalberg C; Emmett A; Merchant K; Knobil K
    Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of budesonide inhalation suspension with four nebulizing solutions.
    McKenzie JE; Cruz-Rivera M
    Ann Pharmacother; 2004 Jun; 38(6):967-72. PubMed ID: 15084687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium.
    Bonasia PJ; McVicar WK; Bill W; Ong S
    Respir Care; 2008 Dec; 53(12):1716-22. PubMed ID: 19025708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol, budesonide, and ipratropium bromide in compounded nebulizer solutions.
    Blewett AJ; Varma D; Gilles T; Butcher R; Jacob J; Amazan J; Jansen SA
    J AOAC Int; 2011; 94(1):110-7. PubMed ID: 21391487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmolality and pH of anti-asthmatic drug solutions.
    Desager KN; Van Bever HP; Stevens WJ
    Agents Actions; 1990 Nov; 31(3-4):225-8. PubMed ID: 2150739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical compatibility of mixtures of dornase alfa and tobramycin containing nebulizer solutions.
    Krämer I; Schwabe A; Lichtinghagen R; Kamin W
    Pediatr Pulmonol; 2009 Feb; 44(2):134-41. PubMed ID: 19061233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.
    El-Gendy N; Pornputtapitak W; Berkland C
    Eur J Pharm Sci; 2011 Nov; 44(4):522-33. PubMed ID: 21964203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
    Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of nebulizer solution admixtures.
    Joseph JC
    Ann Pharmacother; 1997 Apr; 31(4):487-9. PubMed ID: 9101012
    [No Abstract]   [Full Text] [Related]  

  • 16. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition.
    Johnson MA; Newman SP; Bloom R; Talaee N; Clarke SW
    Chest; 1989 Jul; 96(1):6-10. PubMed ID: 2525460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on aerosol performance of mixing of either budesonide or beclomethasone dipropionate with albuterol and ipratropium bromide.
    Melani AS
    Respir Care; 2011 Mar; 56(3):319-26. PubMed ID: 21255509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD.
    Dalal AA; Petersen H; Simoni-Wastila L; Blanchette CM
    J Med Econ; 2009; 12(4):339-47. PubMed ID: 19827993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction.
    Arunthari V; Bruinsma RS; Lee AS; Johnson MM
    Respir Care; 2012 Aug; 57(8):1242-7. PubMed ID: 22348319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
    Lee TY; Chen CM; Lee CN; Chiang YC; Chen HY
    Am J Health Syst Pharm; 2005 Apr; 62(8):828-33. PubMed ID: 15821276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.